NCT02535949View on ClinicalTrials.gov

Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 4, 2017

Study Completion Date

July 7, 2017

Conditions

HemorrhageShockWounds and Injuries

Interventions

DRUG

Tranexamic Acid

Tranexamic acid is a man-made form of an amino acid (protein) called lysine. Tranexamic acid prevents enzymes in the body from breaking down blood clots.

OTHER

Placebo

Matching Volume Normal Saline Placebo given IV over 10 minutes within 2 hours of initial injury

Trial Locations (1)

63110

Barnes Jewish Hospital, St Louis

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Washington University School of Medicine

OTHER

NCT02535949 - Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury | Biotech Hunter | Biotech Hunter